STOCK TITAN

Align Technology Inc - ALGN STOCK NEWS

Welcome to our dedicated page for Align Technology news (Ticker: ALGN), a resource for investors and traders seeking the latest updates and insights on Align Technology stock.

Align Technology Inc. (NASDAQ: ALGN) is a prominent global medical device company known for designing and manufacturing the Invisalign® System, the world’s most advanced clear aligner system, iTero™ intraoral scanners, and exocad™ CAD/CAM software. These innovations enable digital orthodontics and restorative dentistry, improving patient outcomes and practice efficiencies for over 261,000 doctor customers worldwide. Since its establishment, Align Technology has treated over 17.6 million patients with Invisalign, driving the evolution of digital dentistry through the Align Digital Platform™.

The company’s flagship product, the Invisalign System, has revolutionized the approach to orthodontic treatment. Utilized in over 90 countries, Invisalign combines proprietary virtual modeling software and rapid mass-manufacturing processes to develop customized aligners for each patient. It's a preferred choice for treating a wide range of malocclusions, from simple to complex cases. The system has gained the trust of over 230,000 Invisalign-trained dentists and orthodontists globally.

Align Technology also offers the iTero intraoral scanner, which uses advanced parallel confocal imaging technology to capture detailed digital impressions of patients' teeth, facilitating accurate treatment plans and enhancing patient communication. Over 85% of Invisalign cases start with digital scans, underscoring the importance of iTero technology in modern dental practices.

In 2024, the company launched the iTero Lumina™, a next-generation intraoral scanner that offers a 3X wider field of capture with a significantly smaller and lighter wand, providing faster, more accurate scans and superior patient comfort. This innovation exemplifies Align's commitment to continuous improvement and leveraging emerging technologies.

Align’s commitment to innovation is further demonstrated by its recent acquisition of Cubicure GmbH, a pioneer in direct 3D printing solutions. This acquisition strengthens Align’s strategic innovation roadmap and enhances its manufacturing capabilities for 3D printed products such as the Invisalign Palatal Expander System. This new system offers a removable, clinically effective alternative to traditional palatal expanders, further solidifying Align’s position at the forefront of digital orthodontics.

The company’s financial health remains robust, with significant investments in R&D aimed at driving future growth. Align continues to support clinical and scientific research worldwide through its annual Research Awards Program, fostering advancements in dental care.

Align Technology maintains a strong market presence, bolstered by strategic partnerships and a broad product portfolio, ensuring its role as a leader in the rapidly evolving dental industry. For more information, visit www.aligntech.com.

Rhea-AI Summary

Align Technology, Inc. (NASDAQ: ALGN) announces the departure of Yuval Shaked, EVP and Managing Director of iTero scanner and services, after nearly six years for personal reasons. He will assist during the transition to Karim Boussebaa, effective immediately from February 27. Boussebaa, with over 28 years of healthcare leadership experience, previously led multiple business units at Philips Healthcare. President and CEO Joe Hogan praised both Shaked’s contributions and Boussebaa's qualifications, expressing confidence in Boussebaa’s ability to drive growth in the iTero business.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.02%
Tags
management
-
Rhea-AI Summary

Align Technology (NASDAQ: ALGN) has initiated a $250 million accelerated stock repurchase (ASR) agreement with Citibank, part of its $1 billion stock repurchase program. This move showcases the company's strong cash flow and balance sheet health. Align's CFO emphasized confidence in growth opportunities and commitment to enhancing shareholder value through stock buybacks and strategic growth investments. CEO Joe Hogan and CFO John Morici also plan to personally purchase $1.0 million and $0.2 million of stock, respectively. The ASR is expected to conclude by April 26, 2023, and will be funded from the company's cash reserves.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.19%
Tags
buyback
-
Rhea-AI Summary

Align Technology reported Q4 2022 revenues of $901.5 million, reflecting a 1.3% sequential increase but a 12.6% decline year-over-year. Total revenues for 2022 reached $3.7 billion, with $3.1 billion in Clear Aligner revenues. The company faced significant foreign exchange impacts, losing approximately $67.6 million year-over-year in Q4. Net income for Q4 was $41.8 million or $0.54 per diluted share, down 42.5% from Q3. Align plans a new $1 billion stock repurchase program, succeeding the current one, demonstrating confidence in future growth despite macroeconomic challenges.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
27.38%
Tags
Rhea-AI Summary

Align Technology (NASDAQ: ALGN) will announce its fourth-quarter and full-year 2022 financial results on February 1, 2023, after market close at 4:00 p.m. ET. A conference call will follow at 4:30 p.m. ET for investors to discuss these results. Tentative earnings release dates for fiscal 2023 are set for April 26, July 26, and October 25. The information will be accessible on the company's Investor Relations website, along with a telephonic replay available until February 15, 2023.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.65%
Tags
none
-
Rhea-AI Summary

Align Technology (NASDAQ: ALGN) has opened its 2023 Research Award Program, offering up to $300,000 in funding for clinical and scientific dental research globally. Since its inception in 2010, the program has allocated approximately $2.7 million to support dental research. Awards include four one-year grants of up to $25,000 each, available across the Americas, EMEA, and APAC regions. Applications are due by March 3, 2023, with recipients notified by June 5, 2023.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.53%
Tags
none
-
Rhea-AI Summary

Align Technology and Desktop Metal have announced a strategic collaboration to enhance digital restorative dentistry. Align will supply its iTero Element™ Flex intraoral scanners to Desktop Labs, connecting general dentists with a premium lab network in the U.S. This exclusive partnership aims to streamline workflow and improve patient care by enabling dentists to perform full arch scans and send files directly to labs. The collaboration reflects Align's commitment to advancing digital dentistry and improving treatment efficiencies.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.9%
Tags
none
Rhea-AI Summary

Align Technology and Desktop Metal have announced a strategic collaboration to integrate iTero Element Flex intraoral scanners into the Align Digital Platform. This partnership aims to enhance digital restorative dentistry by connecting general dentist locations with Desktop Labs' extensive lab network. The iTero scanner will facilitate better workflows for dentists, enabling efficient communication with labs and quicker patient evaluations. The collaboration signifies a substantial step toward advancing digital dentistry and improving patient care.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.9%
Tags
none
-
Rhea-AI Summary

Align Technology has announced a new accelerated stock repurchase agreement (ASR) to buy back $200 million of its common stock, part of a $1 billion repurchase program initiated in May 2021. CEO Joe Hogan will personally purchase an additional $2 million of Align shares, enhancing shareholder value. As of September 30, 2022, Align had approximately $1.1 billion in cash and 78.2 million shares outstanding. The ASR is expected to be completed by February 1, 2023.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.01%
Tags
buyback
-
Rhea-AI Summary

Align Technology reported Q3'22 results with total revenues of $890.3 million, down 12.4% year-over-year. Clear Aligner revenues declined 12.5% year-over-year, totaling $732.8 million. The company faced substantial foreign exchange impacts, decreasing revenues by $57.4 million year-over-year. Operating income was $143.7 million with a 16.1% operating margin, impacted by foreign exchange as well. Align celebrated reaching 14 million Invisalign patients and opened its first EMEA manufacturing facility in Poland.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-18.1%
Tags
Rhea-AI Summary

Align Technology has announced the release of the iTero-exocad Connector, enhancing digital workflows for dental professionals. This integration allows users to visualize tooth structures using iTero intraoral cameras and NIRI images within the exocad DentalCAD 3.1 Rijeka software. Available for iTero Element 5D systems, this innovation streamlines design processes, enabling lab technicians to begin designing restorations with a single click. The release is effective from October 3, 2022, and is aimed at improving communication between labs and doctors, ultimately enhancing patient care.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.62%
Tags
none

FAQ

What is the current stock price of Align Technology (ALGN)?

The current stock price of Align Technology (ALGN) is $211.06 as of December 20, 2024.

What is the market cap of Align Technology (ALGN)?

The market cap of Align Technology (ALGN) is approximately 15.9B.

What is Align Technology's main product?

Align Technology’s main product is the Invisalign® System, the world’s most advanced clear aligner system.

How many patients have been treated with Invisalign?

Since its launch, Invisalign has treated over 17.6 million patients worldwide.

What technologies does Align Technology offer?

Align Technology offers Invisalign® clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software.

What is the iTero Lumina™ scanner?

The iTero Lumina™ is a next-generation intraoral scanner providing a wider field of capture, faster and more accurate scans, and superior patient comfort.

What was the purpose of acquiring Cubicure GmbH?

The acquisition of Cubicure GmbH aims to enhance Align’s 3D printing capabilities, supporting the development of innovative orthodontic solutions like the Invisalign Palatal Expander System.

How does Align Technology support scientific research?

Align Technology supports scientific research through its annual Research Awards Program, providing grants to universities for advancing dental care.

What is the Align Digital Platform?

The Align Digital Platform™ is an integrated suite of proprietary technologies and services designed to enhance digital orthodontic and restorative workflows.

How many Invisalign-trained doctors are there globally?

There are over 230,000 Invisalign-trained dentists and orthodontists worldwide.

What is the financial outlook for Align Technology?

Align Technology maintains robust financial health, with continuous investments in R&D and strategic acquisitions to drive future growth.

Where can I find more information about Align Technology’s products?

For more information, visit www.aligntech.com, www.invisalign.com, www.itero.com, or www.exocad.com.

Align Technology Inc

Nasdaq:ALGN

ALGN Rankings

ALGN Stock Data

15.94B
69.72M
6.6%
89.99%
4.01%
Medical Instruments & Supplies
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Link
United States of America
TEMPE